1. Activation of the mTOR pathway enhances PPARγ/SREBP-mediated lipid synthesis in human meibomian gland epithelial cells.
- Author
-
Jun I, Choi YJ, Kim BR, Lee HK, Seo KY, and Kim TI
- Subjects
- Humans, Cell Differentiation drug effects, Sirolimus pharmacology, Lipid Metabolism, Phosphorylation, Mechanistic Target of Rapamycin Complex 1 metabolism, Cells, Cultured, Meibomian Glands metabolism, Meibomian Glands cytology, TOR Serine-Threonine Kinases metabolism, Epithelial Cells metabolism, Epithelial Cells drug effects, PPAR gamma metabolism, Signal Transduction, Sterol Regulatory Element Binding Protein 1 metabolism, Sterol Regulatory Element Binding Protein 1 genetics, Lipogenesis drug effects
- Abstract
The involvement of the mechanistic targets of rapamycin (mTOR) pathway in lipid metabolism has been recently elucidated. However, its specific role in the Meibomian gland, where lipid metabolism is significant, remains not fully understood. We investigated the role of mTOR signaling system in the lipogenesis and differentiation of human meibomian gland epithelial cells (HMGECs). Treatment of HMGECs with rapamycin resulted in a reduction in lipid synthesis and the expression of PPARγ and SREBP-1, the major regulators of lipid synthesis. The phosphorylation of p70S6kinase and AKT, which are downstream signals of mTOR complexes 1 and 2, respectively, decreased following rapamycin treatment. In addition, when both mTOR complex 1 and 2 were suppressed using siRNA, there was a significant reduction in the expression of PPARγ and SREBP-1, along with a decrease in lipid synthesis in HMGECs. Our findings suggest that inhibiting the mTOR pathway diminishes the differentiation and adipogenesis of meibomian gland epithelial cells, and both mTOR complexes 1 and 2 appear to play a role in this activity., Competing Interests: Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF